PROGNOSTICS IN-MED PRIVATE LIMITED

In their own words

Preventive brain health is an emerging space towards overall fitness - mind, body and soul. Brain Volume Quantification is the tool, which has the potential to contribute substantially to mental health. Our Product, NeuroshieldTM is a brain geometry based quantification report and will enhance Neuro-imaging to add value and enhance the Radiology report into specific volumetric measures and enable actionable, quantitative data to differential diagnosis for the Neuro-physician. In-Med Prognostics, a US based Healthcare Startup by Indo-US Entrepreneurs. The endeavour of the company's product - NeuroShieldTM is an algorithm which deploys the application of multimodal brain imaging toward early identification of subclinical brain disease prevention through the influence of modifiable risk factors. Positioned at the intersection of neurology and psychiatry, it has applications in a multitude of diseases including age-related cognitive decline, mood and psychotic disorders, and a variety of other neuropsychiatric conditions. Our unique offering is building the Indian baseline for the country specific volume brain structure markings and would be also collaborating with Multi Imaging Modal Analysis team at NIMHANS, Bengaluru and Symbiosis Imaging analysis center of excellence (Dr. Madhura Inghalikar) "The automated segmentation of NeuroShieldTM tool enhances the capabilities that are now out there seem like such a simple step. This will enable to have a rational and straight forward approach to unleash a whole host of other quantitative biomarker data that will be powerful in many mental diseases - Neurological and psychiatric. Alzheimer's will be one of the interesting anomalies as a test case. Quoted by a leading Neuro Physician from Pune, India.

Written by the company on its public Startup India profile. Not verified by us.